BOLT BIOTHERAPEUTICS INC

BOLT · NASDAQ

Updated at 2026-10-13 11:37:13

----
Today's High
--
Today’s Low
--
BOLT BIOTHERAPEUTICS INC (BOLT) Stock Price & Market Data
Search empty state illustration
...

Candlestick trends are for reference. Refer to the trading page for actual data.

Key Statistics

Previous Open
$4.13
Previous Close
$4.24
Volume
28.72K
Market Cap
$8.16M
P/E Ratio
--
EPS
$-16.44

Previous Day Range

$4.13$4.67

52-Week Range

$3.10$7.19

Company Overview

Sector
HEALTHCARE
Industry
Biotechnology
Sub-industry
BIOTECHNOLOGY
Headquarters
900 CHESAPEAKE DRIVE, REDWOOD CITY, CA, UNITED STATES, 94063
Country
US
Listing Date
2021-02-05
Fiscal Year End
December
Shares Outstanding
1.92M
CIK
0001641281

Bolt Biotherapeutics, Inc., a clinical-stage immuno-oncology company, is dedicated to the discovery, development and commercialization of pharmaceutical products. The company is headquartered in Redwood city, California.

Financial Metrics

Revenue

2026-06-30

$5K

2026-03-31

$26K

2025-12-31

$2.5M

2025-09-30

$2.16M

Operating Expenses

2026-06-30

$8.37M

2026-03-31

$7.42M

2025-12-31

$8.1M

2025-09-30

$9.87M

Net Income

2026-06-30

-$7.72M

2026-03-31

-$7.24M

2025-12-31

-$6.63M

2025-09-30

-$7.14M

Net Profit Margin

2026-06-30

-154.4K%

2026-03-31

-27.86K%

2025-12-31

-265.24%

2025-09-30

-329.36%

Earnings Per Share

2026-06-30

$-4.57

2026-03-31

$-4.31

2025-12-31

$-2.98

2025-09-30

$-3.72

Earnings Before Interest, Taxes, Depreciation, and Amortization

2026-06-30

-$7.54M

2026-03-31

-$7.04M

2025-12-31

-$6.37M

2025-09-30

-$6.85M

Effective Tax Rate

2026-06-30

--

2026-03-31

--

2025-12-31

--

2025-09-30

--

FAQs

Risk Warning

Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.